Skip to main content
. 2020 Nov 30;14(2):617–624. doi: 10.1111/cts.12922

Figure 1.

Figure 1

Example screenshots of the personalized PRA‐based smartphone app. Anti‐R, anti‐renin drugs including angiotensin converting enzyme (ACE) inhibitors, angiotensin receptor blockers (ARBs), β‐blockers, direct renin inhibitors and central α2‐agonists; Anti‐V, anti‐volume drugs including diuretics, aldosterone receptor antagonists, calcium channel blockers, vasodilators and α1‐blockers; BP, blood pressure; HTN, hypertension; PRA, plasma renin activity.